IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tekla Capital Management LLC

Q3 2014 Holdings

Filed 2014-11-14 | 108 holdings | $158.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Gilead Sciences, Inc.(GILD)Common375558103$265.1K2,490,5310.2%
Agios Pharmaceuticals, Inc.(AGIO)Common00847X104$2.1M35,0001.4%
Align Technology, Inc.(ALGN)Common016255101$3.6M70,4002.3%
Alnylam Pharmaceuticals, Inc.(ALNY)Common02043Q107$4.8M61,5953.0%
Accuray, Inc.(ARAY)Common004397105$5.3M731,9433.3%
AbbVie Inc.(ABBV)Common00287Y109$27.8M481,21917.5%
BioMarin Pharmaceutical Inc.(BMRN)Common09061G101$51.3M710,52732.3%
Biogen Idec, Inc.(BIIB)Common09062X103$61.8M186,78338.9%
PreviousPage 3 of 3